Oppenheimer & Co. Inc. Buys 525 Shares of CME Group Inc. (NASDAQ:CME)

Oppenheimer & Co. Inc. boosted its position in shares of CME Group Inc. (NASDAQ:CME) by 1.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 36,242 shares of the financial services provider’s stock after acquiring an additional 525 shares during the period. Oppenheimer & Co. Inc.’s holdings in CME Group were worth $7,125,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in CME. Bluefin Capital Management LLC bought a new stake in shares of CME Group during the 4th quarter valued at $2,891,000. Alaska Permanent Fund Corp raised its holdings in CME Group by 81.4% during the first quarter. Alaska Permanent Fund Corp now owns 44,534 shares of the financial services provider’s stock valued at $9,588,000 after acquiring an additional 19,985 shares during the period. Western Pacific Wealth Management LP lifted its position in shares of CME Group by 20.2% in the fourth quarter. Western Pacific Wealth Management LP now owns 523 shares of the financial services provider’s stock valued at $110,000 after acquiring an additional 88 shares in the last quarter. Bank of Nova Scotia boosted its stake in shares of CME Group by 229.4% in the fourth quarter. Bank of Nova Scotia now owns 292,597 shares of the financial services provider’s stock worth $61,618,000 after acquiring an additional 203,769 shares during the period. Finally, Oak Harvest Investment Services grew its position in shares of CME Group by 66.5% during the first quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock worth $9,708,000 after purchasing an additional 18,017 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

CME has been the topic of a number of research analyst reports. Barclays boosted their price target on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a report on Thursday, August 15th. JPMorgan Chase & Co. raised their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Bank of America cut shares of CME Group from a “neutral” rating to an “underperform” rating and decreased their price target for the stock from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Finally, Piper Sandler restated an “overweight” rating and set a $225.00 price objective on shares of CME Group in a research report on Tuesday, August 20th. Four investment analysts have rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $209.73.

CME Group Stock Down 0.1 %

Shares of NASDAQ:CME opened at $216.99 on Friday. The company has a market cap of $78.13 billion, a price-to-earnings ratio of 24.69, a PEG ratio of 8.85 and a beta of 0.55. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $223.80. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a 50-day moving average price of $205.69 and a 200 day moving average price of $207.67.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.53 by $0.03. The business had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company’s revenue for the quarter was up 12.7% on a year-over-year basis. During the same period last year, the company earned $2.30 EPS. As a group, equities research analysts predict that CME Group Inc. will post 9.94 earnings per share for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.12%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s payout ratio is 52.33%.

Insiders Place Their Bets

In related news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.30% of the stock is owned by insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.